Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-06-001311
Filing Date
2006-03-16
Accepted
2006-03-16 13:47:21
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w18549e10vk.htm 10-K 987560
2 EXHIBIT 12 w18549exv12.htm EX-12 23954
3 EXHIBIT 21 w18549exv21.htm EX-21 5008
4 EXHIBIT 23 w18549exv23.htm EX-23 2898
5 EXHIBIT 31.1 w18549exv31w1.htm EX-31.1 6031
6 EXHIBIT 31.2 w18549exv31w2.htm EX-31.2 6032
7 EXHIBIT 32.1 w18549exv32w1.htm EX-32.1 3710
8 EXHIBIT 32.2 w18549exv32w2.htm EX-32.2 3716
  Complete submission text file 0000950133-06-001311.txt   1040447
Mailing Address 5775 WEST OLD SHAKOPEE RD SUITE 100 MINNEAPOLIS MN 55437
Business Address 5775 WEST OLD SHAKOPEE RD SUITE 100 BLOOMINGTON MN 55437 952-346-4700
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10736 | Film No.: 06691086
SIC: 2834 Pharmaceutical Preparations